Central serous chorioretinopathy after bone marrow transplantation.
OBJECTIVE
To describe central serous chorioretinopathy after bone marrow transplantation.


METHODS
The medical records of the patient were reviewed retrospectively.


RESULTS
A 46-year-old Filipino man developed multifocal central serous chorioretinopathy affecting his left eye 4 months after bone marrow transplantation for acute myelogenous leukemia. Other co-existing medical problems at the time of presentation included systemic hypertension and graft-versus-host-disease (GVHD), for which the patient was using both systemic corticosteroids and cyclosporine.


CONCLUSIONS
Central serous chorioretinopathy is a rare cause of vision loss in patients after bone marrow transplantation. Previous descriptions of bone marrow transplantation-associated central serous chorioretinopathy in patients with thrombotic microangiopathy, as well as the occurrence of both systemic hypertension and the use of systemic corticosteroids and cyclosporine in our patient with bone marrow transplantation-associated central serous chorioretinopathy, support theories of choroidal vascular compromise in the pathogenesis of central serous chorioretinopathy.
Fawzi
A A
AA
Francis I. Proctor Foundation and Department of Ophthalmogy, University of California at San Francisco, School of Medicine, San Francisco, California 94143, USA.
Cunningham
E T
ET
D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D015862:Choroid Diseases / Q000209:etiology*; D017809:Fatal Outcome; D005451:Fluorescein Angiography; D006801:Humans; D008297:Male; D008875:Middle Aged; D012163:Retinal Detachment / Q000209:etiology / Q000473:pathology; D012164:Retinal Diseases / Q000209:etiology* / Q000473:pathology; D012189:Retrospective Studies